Syntheses, cytotoxic activity evaluation and HQSAR study of 1,2,3-triazole-linked isosteviol derivatives as potential anticancer agents
[Display omitted] •A series of novel 1,2,3-triazole-linked isosteviol derivatives were synthesized.•Their cytotoxicities were assessed against HCT-116 and JEKO-1cell lines.•Compound 10b is promising anticancer agent against HCT-116 (IC50=2.987±0.098μM).•HQSAR studies revealed good predictive model....
Saved in:
Published in | Bioorganic & medicinal chemistry letters Vol. 26; no. 22; pp. 5455 - 5461 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
OXFORD
Elsevier Ltd
15.11.2016
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | [Display omitted]
•A series of novel 1,2,3-triazole-linked isosteviol derivatives were synthesized.•Their cytotoxicities were assessed against HCT-116 and JEKO-1cell lines.•Compound 10b is promising anticancer agent against HCT-116 (IC50=2.987±0.098μM).•HQSAR studies revealed good predictive model.
A series of novel 1,2,3-triazole-linked isosteviol derivatives were designed and synthesized via Huisgen-click reaction. Their cytotoxicities in vitro against HCT-116 and JEKO-1 cells were screened. The preliminary bioassays indicated that most of the title compounds exhibited noteworthy cytotoxic activities. Particularly, the compound 10b revealed the most potent inhibitory activities against HCT-116 cells with IC50 value of 2.987±0.098μM, which was better than that (3.906±0.261μM) of positive control cisplatin. On the basis of these bioactivity data, hologram quantitative structure–activity relationship (HQSAR) was performed, and a statistically reliable model with good predictive power (r2=0.848, q2=0.544 and R2pred=0.982) was achieved. Additionally, the contribution maps derived from the optimal model explained the individual atomic contributions to the activity for each molecule. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2016.10.028 |